Cephradine and Liver function test abnormal - a phase IV clinical study of FDA data

Summary:

Liver function test abnormal is reported as a side effect among people who take Cephradine (cephradine), especially for people who are female, 0-1 old, have been taking the drug for < 1 month also take Fluoxetine, and have Back disorder.

The phase IV clinical study analyzes which people have Liver function test abnormal when taking Cephradine. It is created by eHealthMe based on reports of 347 people who have side effects when taking Cephradine from the FDA, and is updated regularly.

What is Cephradine?

Cephradine has active ingredients of cephradine. eHealthMe is studying from 351 Cephradine users. Check the latest studies of Cephradine.

What is Liver function test abnormal?

Liver function test abnormal is found to be associated with 1,496 drugs and 1,963 conditions by eHealthMe. Check the latest studies of Liver function test abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

347 people reported to have side effects when taking Cephradine.
Among them, 21 people (6.05%) have Liver function test abnormal.

Could Cephradine cause Liver function test abnormal?

Among these 21 people:

How long have people been on Cephradine when they have Liver function test abnormal? *

What is the gender of people who have Liver function test abnormal when taking Cephradine? *

female: 89.47 %
male: 10.53 %

What is the age of people who have Liver function test abnormal when taking Cephradine? *

What are other drugs people take besides Cephradine? *

What are other side effects people have besides Liver function test abnormal? *

Hepatic Function Abnormal: 19 people, 90.48%
Malaise (a feeling of general discomfort or uneasiness): 19 people, 90.48%
Drug Withdrawal Syndrome Neonatal (prenatal nas is caused by discontinuation of drugs taken by the pregnant mother): 19 people, 90.48%
Foetal Arrhythmia (abnormal rate or rhythm of the foetus heartbeat): 19 people, 90.48%
Foetal Monitoring Abnormal: 19 people, 90.48%
Heart Rate Irregular: 19 people, 90.48%
Hepatotoxicity (chemical-driven liver damage): 19 people, 90.48%
Jaundice Neonatal (yellowing of skin in neonate): 19 people, 90.48%
Low Birth Weight Baby: 19 people, 90.48%
Developmental Delay: 19 people, 90.48%

What are the existing conditions these people have? *

Pelvic Pain: 17 people, 80.95%
Kidney Infection (Pyelonephritis): 17 people, 80.95%
Back Disorder: 17 people, 80.95%
Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 15 people, 71.43%
Back Pain: 2 people, 9.52%
Urinary Tract Infection: 1 person, 4.76%
Pneumonia: 1 person, 4.76%
Hiv Infection: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Cephradine and have Liver function test abnormal?

- Check whether Liver function test abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cephradine:

Cephradine (351 reports)

Browse all side effects of Cephradine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Liver function test abnormal:

Liver function test abnormal (1,496 drugs)

Browse all the conditions that are associated with Liver function test abnormal:

Liver function test abnormal (1,963 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cephradine (the active ingredients of Cephradine) and Cephradine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.